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The high demand of the increasing world population is
resulting in the fast depletion of natural resources as well
as challenging the long-term sustainability of natural
ecosystems. This is clearly reflected in the environmen-
tal impact associated with the use of petroleum-based
plastic materials. For instance, 8.3 billion tonnes of syn-
thetic plastics were globally produced since the early
1950s (Geyer et al., 2017) and current estimates indi-
cate that their production will reach 33 billion tonnes by
2050 (Rhodes, 2018). While not even 10% of the global
plastic waste is annually recycled (Brooks et al., 2018),
the remaining plastic waste ends up in landfills, oceans
or is incinerated (Drzyzga and Prieto, 2019), which
results in enormous amounts of recalcitrant residues
contaminating and accumulating in the environment.
Consequently, the development of environmentally safe
materials that replace petroleum-based plastics is
urgently needed and biopolymers are among the best
alternative to be considered.
Biopolymers are polymeric biomolecules synthesized
by animals, plants and microorganisms, but also include
those polymers that are chemically produced from
renewable resources (i.e. corn, sugar, starch; Niaouna-
kis, 2015). These biopolymers stand out due to their
biodegradability, biocompatibility and functional versatil-
ity. In fact, among their broad range of applications,
biopolymers are currently used for numerous medical,
dental and pharmaceutical purposes, cosmetics and
electronics, as well as clothing fabrics, food additives
and industrial plastics (Freitas et al., 2011; Niaounakis,
2015; Schmid et al., 2015; Avila Rodriguez et al., 2018;
Garcıa and Prieto, 2019; Jacek et al., 2019; Portela
et al., 2019; Wroblewska-Krepsztul et al., 2019).
Since the first discovery of a bacterial polymer in the
nineteenth century (Pasteur, 1861), a vast number of
new biopolymers was identified (Rehm, 2010; Freitas
et al., 2011; Schmid et al., 2015). Based on their compo-
sition, bacterial polymers are categorized into four main
classes: polysaccharides (e.g. xanthan, dextran, algi-
nate, cellulose), polyesters (e.g. polyhydroxyalkanoates),
polyanhydrides (e.g. inorganic polyphosphate) and poly-
amides (e.g. cyanophycin, poly-c-glutamate) (Rehm,
2010; Freitas et al., 2011). However, the advancement
of genomics and genome mining strategies continues to
reveal the extraordinary genetic potential of bacteria as
a source of novel biopolymers. Among other benefits,
the production of these polymers provides bacteria with
protection against biotic and abiotic stresses, as well as
serving as storage of carbon and energy (Rehm, 2010;
Perez-Mendoza and Sanjuan, 2016).
Two of the main medically and industrially relevant
biopolymers worldwide are cellulose and alginate. The
global market for these two polymers currently amounts
to over USD 22 billion per year, with projections to reach
USD 50 billion by 2025 (Anderson et al., 2018). At pre-
sent, plants and algae are almost exclusively the sole
sources of commercially available cellulose and alginate,
respectively (Hay et al., 2013; Heinze, 2016; Garcıa and
Prieto, 2019). However, multiple bacteria have been
found to produce these polymers and the commercial
potential of bacterial cellulose (BC; also known as bacte-
rial nanocellulose) and alginate has extensively been
recognized (Hay et al., 2013; Portela et al., 2019). Thus,
for example, BC shows great potential as a novel wound
healing promoting material and several BC-based medi-
cal and cosmetic products are commercially available,
including CELMAT from Bowil Biotech (Poland),
BASYC from POLYMET Jena (Germany) and Secu-
rian from Xylos (USA). Nevertheless, the major bottle-
neck currently restricting industrial production and
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applicability of bacterial polymers is associated with their
high production costs (Mozejko-Ciesielska and Kiewisz,
2016; Azeredo et al., 2019). Therefore, in order to
improve the production yield of bacterial polymers, vari-
ables such as the bacterial producer strain and its
growth conditions must be optimized (Azeredo et al.,
2019; Jacek et al., 2019). Furthermore, the composition
of the culture media not only affects production yields
but also determines the morphology of the biomaterials
and their physical properties (Singhsa et al., 2018; Azer-
edo et al., 2019). This is illustrated in the case of BC
since there are still many drawbacks to scale up the pro-
duction of this biopolymer and to reduce its currently
high production costs. Importantly, physical properties
(i.e. polymerization, fibril diameter, thermal stability) of
BC are still unexplored and since they are key determi-
nants influencing the final application of the biopolymer
(Singhsa et al., 2018; Azeredo et al., 2019), research in
this area is needed. With this aim, Chen and co-workers
recently evaluated the impact of different carbon sources
derived from plant biomass on the productivity and qual-
ity of BC produced by the model bacterium Koma-
gataeibacter xylinus ATCC 23770. In this report, the
authors demonstrated that bacteria grown in culture
media based on glucose or maltose achieved higher pro-
ductivity, polymerization degree and thermal stability as
compared with bacteria grown on the same media sup-
plemented with alternative sugars (e.g. xylose, mannose
or galactose). Remarkably, when the strain ATCC 23770
was grown in a medium containing a sugar mixture that
mimics a lignocellulosic hydrolysate, BC productivity and
yield were enhanced but other parameters like fibril
diameter, polymerization degree, crystallinity and thermal
stability were reduced (Chen et al., 2019). Overall, fur-
ther investigations are required to link sugar metabolism
with BC yield and quality – a research field with evident
biomedical and industrial applications.
The biosynthesis of polymers is energetically demand-
ing for bacteria, and their production is frequently highly
regulated, with many biosynthetic gene clusters being
cryptic under standard culture conditions (Rehm, 2010;
Hay et al., 2014; Schmid et al., 2015; Perez-Mendoza
and Sanjuan, 2016). As a result, future synthetic biology
strategies will be focused not only on developing a-la-
carte bacterial polymers with specific chemical and phys-
ical properties but also on the construction of bacterial
strains with improved production yields (Anderson et al.,
2018). This issue has been addressed by Valentine and
co-workers in a recent report published in Microbial
Biotechnology using Pseudomonas aeruginosa PAO1 as
model bacterium (Valentine et al., 2019). The major
exopolysaccharide produced by this strain is alginate
(Maunders and Welch, 2017). However, P. aeruginosa is
a common opportunistic pathogen, which limits its use
as a source of commercial alginate. In addition, the syn-
thesis of this polymer by P. aeruginosa is tightly con-
trolled (Hay et al., 2014). One of the key players in this
complex regulatory circuit is MucE, an outer membrane
protein that when overexpressed leads to an increased
expression of the alginate biosynthetic gene cluster (Qiu
et al., 2007). In order to use P. aeruginosa as a potential
producer of commercial alginate, Valentine and co-work-
ers engineered the strain P. aeruginosa PGN5, in which
five key virulence genes of PAO1 were deleted. These
deletions did not affect the capacity of PGN5 to synthe-
size alginate, either at the structural or at the concentra-
tion levels. Indeed, MucE overexpression in PGN5
resulted in overproduction of alginate, even at higher
levels than when MucE was overexpressed in the wild-
type strain. Remarkably, the authors showed that PGN5
was avirulent in mice models with no mortality observed
after 4 weeks post-infection. In contrast, 95% and 20%
mortality were quantified within 48 h when mice were
injected with wild-type P. aeruginosa and the Food and
Drug Administration (FDA) approved Escherichia coli
strain BL21, respectively. By tagging the genomes of
PAO1 and PGN5 with the lux operon, the authors
demonstrated that the avirulent phenotype of PGN5 was
associated with its impaired ability to spread in mice
models since no bacterial dissemination from the injec-
tion site was observed. Altogether, given the reduced
toxicity and invasiveness of PGN5, Valentine et al.
(2019) highlighted the potential use of this strain not only
as an alternative to algae as a commercial source of
alginate but also as a microbial cell factory for the pro-
duction of alginates with specific chemical and physical
properties.
Despite improvements in metabolic engineering and
synthetic biology strategies for microbial synthesis of
biopolymers, the development of novel technologies to
improve bacterial production yields from natural sources
is still a challenge. For example, redirecting carbon
fluxes and the use of novel gene-editing technologies
like CRISPR-Cas9 are potential strategies to be
exploited. Exploring novel sequences and protein func-
tions will additionally be a powerful route to generate
new functional biomaterials by synthetic biology methods
(Anderson et al., 2018). However, parameters such as
energy and material efficiency and process economics
need to be optimized to consider bacterial polymer pro-
duction as a green technology (Anderson et al., 2018).
Remarkably, the use of toxic aromatic hydrocarbons
(e.g. naphthalene) as a carbon source for biopolymer
production has been successfully explored recently
(Marin et al., 2019). This approach will lay the foundation
for coupling the bioremediation of toxic compounds with
the generation of value-added biopolymers exhibiting a
wide range of biotechnological applications.
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